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 Smoking represents an important and rapidly growing global cause of 
cardiovascular mortality and morbidity.Cigarrette smoking is one of the 
major modifiable risk factors of cardiovascular disease, unless smokers are 
able to quit,  approximately 40% of them will die prematurely.The need of 
the hour is timely intervention through smoking cessation.Our study was 
carried out in young smokers to demonstrate the effects of smoking on lipid 
profile and electrocardiographic changes. We aimed to study the effect of 
smoking on lipid profile and electrocardiographic changes in young 
smokers.The study design was a cross sectional study comprising 75 male 
smokers and 75 healthy controls.Smoking history and physical examination 
was done .Fasting sample was analysed for lipid profile and 
electrocardiograph of all subjects were recorded.The statistical anaylsis 
between mean values were evaluated by student‘t’ test. Statistical 
significance was assessed by chi-square test, p<0.001 was considered to be 
significant.The mean pulse rate,  the mean systolic blood pressure,  abnormal 
lipid profile and prolonged Qt interval were significantly higher in smokers 
(p<0.001).We demonstrated significant lipid abnormalities and 
electrocardiographic changes in young smokers who form an important risk 
group and target population in whom smoking cessation counseling should 
be carried out to decrease long term cardiovascular risk. 
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1. INTRODUCTION 
Smoking represents an important and rapidly growing global cause of cardiovascular mortality and 
morbidity[1, 2].Worldwide, 1.2 billion people smoked in 2000, a number that is projected to increase to 1.6 
billion by 2030.[3] 
The earliest epidemiological study to demonstrate the association between smoking and ischemic 
heart disease(IHD) were the Framingham study and Sir Richard Doll’s classic study of British doctors [4, 5]. 
Cigarrette smoking is one of the major modifiable risk factors of cardiovascular disease,  in the form 
of atherosclerosis and coronary artery disease(CAD ), unless smokers are able to quit,  approximately 40% of 
them will die prematurely.It accelerates the atherosclerotic process by its proatherosclerotic and 
prothromboticactions.Acute events such as ventricular fibrillation, and sudden cardiac death are also 
increased by smoking, particularly in the presence of pre existing coronary heart disease(CHD) by 
augmenting the autonomic system [3]. 
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The overall prevalence of current smoking was 15.5%(29.3% among males &0.6% among females) 
in Karnataka a survey conducted by ICMR with financial support by WHO in 2000[4] 
Thus the need of the hour is timely intervention through smoking cessation.Our study was carried 
out in young smokers to demonstrate the effects of smoking on lipid profile and electrocardiographic 
changes,  and the potential benefits of primordial prevention in such populations. To study the effects of 
smoking on lipid profile and electrocardiographic changes in young smokers. 
 
 
2. RESEARCH METHOD 
The study design was a cross sectional study comprising of 150 male subjects, 75 smokers and 75 
age and sex matched healthy controls. 
Inclusion criteria: 
Smokers in the age group 25-40 years who smoked for atleast one year.Exclusion criteria:Patients with 
1) Diabetes mellitus 
2) Hypertension 
3) Renal disease 
4) Hepatic disease 
5) Obesity 
6) History of alcohol abuse 
7) Drugs which can alter lipid profile and cause ECG abnormalities 
A detailed history with emphasis on duration and number of cigarette/bidis smoked was taken. 
Smokers were divided in to two categories 
1) Depending on the number of years of smoking: 
 1-5 years 
 5-10 years 
 >10 years 
2) Depending on the number of cigarettes/bidis smoked 
 Light smokers-1-20 cigarette/bidi per day 
 Heavy smokers >20/day 
A detailed general physical examination with vital signs and cardiovascular system examination was 
carried out. 
 
Biochemical analysis 
Blood sample was taken in fasting state for analysis of total cholesterol,  LDL,  HDL, triglycerides, 
V LDL, which was estimated by enzymatic colorimetric method. Electrocardiograph was taken for all 
subjects and analysed for any cardiac abnormality in terms of rate, axisdeviation,  conductiondefect,  
arrhythmia,  chamber hypertrophy or changes suggestive of ischemia. 
 
 
3. RESULTS AND ANALYSIS 
The study design was a cross sectional study, we studied 150 male subjects, of which75 were 
smokers and 75 age and sex matched healthy non smokers.The mean age was 32.08 among  non smokers and 
31.93 in smokers. There was no difference noticed among the groups with reference to diet and physical 
activity. 
Distribution according to number of years of smoking and number of cigarette per dayOf the 75 
smokers, 34 subjects smoked upto 20 cigarettes/day for 5-10 years(43.3%), 16 smoked for 1-5 years(21.3%) 
and 8  smoked for more than 10 years(10%).17 subjects smoked more than 20 cigarettes for more than 10 
years(22.6%) 
 
Statistical Analysis 
The differences between mean values were evaluated by student ‘t’ test. The statistical significance 
was assessed by using chi-square test, p<0.001 was considered to be significant. 
The mean pulse rate was higher in smokers 81.16 vs 74.81, the mean systolic blood pressure was 
significantly higher in smokers 124.19 vs 115.97 in non smokers(p<0.001) Table 1. 
The lipid profile among smokers were comparatively higher(p<0.001) than in non smokers,  with a 
lower HDL level among smokers.Also as the duration of smoking and number of cigarettes increased so did 
the lipid abnormalities (Figure 1). 
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4. DISCUSSION 
Ciagarette smoking is reported to be associated with an average 70% increase in the risk of death 
from coronary artery diseas e[6]. It has been observed that smoking affects lipid profile and increases the risk 
of cardiovascular death.Thus measurement of lipid profile in clinical laboratory has become increasingly 
important because of predictive association with coronary heart disease [7]. 
In a study conducted by Craig et al it was observed that young smokers are relatively at a higher risk 
of developing cardiovascular disease (CVD) compared to older adults[7], our study comprised of subjects 
were in the age group 25-30, they form the productive work force of the society and hence were studied to 
reflect the impact it might have with respect to cardiovascular disease and economic burden in future. 
In our study smokers had a significantly higher pulse rate and systolic blood pressure compared to 
non smokers.Nicotine and one or more toxic agents in cigarette smoke are implicated in the pathogenesis. 
Although tachycardia during smoking contributes to increase in blood pressure,  other mechanisms by which 
cigarette smoking may raise blood pressure include α1 adrenoreceptor mediated vasoconstriction,  
vasopressin release and possible direct effects on endothelial function[8]. 
Abnormal lipid levels and smoking are the two most important risk factors for having a heart 
attack[4]. High cholesterol levels are estimated to cause 56% of ischemic heart disease and 18% of strokes,  
amounting to 4.4 million deaths annually[9]. In our study we found that smokers had significantly higher 
level of lipid abnormalities and a lower HDL. Direct relationship of smoking towards CHD has been 
mentioned in MRFIT trial,  it was described that increase in HDL 1mg/dl was associated with decrease in the 
risk of CHD[10].The incidence of developing CVD is directly related to the number of cigarettes 
smoked[11].In our study we were able to show a direct correlation between duration and number of cigarettes 
smoked with the magnitude of dyslipidemia. These results were in conformity with a study conducted by 
Ramachandran et al[12]. 
Smoking is also known to induce autonomic changes and may precipitate arrhythmias and sudden 
cardiac death. In our study the QTc was found to be prolonged among smokers,  this may increase the 
threshold for arrhythmias,  and QTc prolongation may double the risk for sudden cardiac death as studied by 
Okin PM et al[13]. 
Thus this study demonstrated significant lipid abnormalities and electrocardiographic changes in 
young smokers who form an important risk group and a target population in whom smoking cessation 
counseling should be carried out to decrease long term cardiovascular risk. 
 
 
5. CONCLUSION 
In a country like ours where tobacco represents an important cash crop and a source of employment,  
two things that are often in short supply, the smoking rates among men are staggeringly high. If the current 
smoking pattern continues by 2030 the global burden of disease attributable to tobacco will reach 10 million 
deaths annually,  thus prevention through health education is imperative to bring down mortality and 
morbidity due to cardiovascular disease contributed to by smoking. 
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